Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Hypervision proton surgery

Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

Ketogenic diet

LOC387715/HTRA1 genotyping

Lactose-free milk formula (Frisolac LF ®)

Linked Color Imaging

Liquid Biopsy (SPOT-MAS Assay)

LiveSpo Navax

Low dose midazolam

Lugol's Solution (1.5%)

MR/PET

Magnesium Sulfate

Medical treatment alone

Midazolam 0.03mg/kg

Midazolam premedication

Miyarisan-BM (Clostridium Butyricum Miyairi)

Mupirocin

Mupirocin (drug)

Omeprazole

Oral fluid

Oral microbiota

PG102P

Placebo

Placebo

Frequently asked questions